120 related articles for article (PubMed ID: 7923471)
1. Synthesis and aldose reductase inhibitory activity of 2-substituted 6-fluoro-2,3-dihydrospiro[4H-1-benzopyran-4,4'-imidazolidine]-2',5'-dio nes.
Unno R; Yamaguchi T; Usui T; Kakigami T; Fukushima M; Mizuno K; Baba Y; Kurono M
Chem Pharm Bull (Tokyo); 1994 Jul; 42(7):1474-8. PubMed ID: 7923471
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and aldose reductase inhibitory activity of 2-substituted-6-fluoro-2,3-dihydrospiro [4H-1-benzopyran-4, 4'-imidazolidine]-2',5'-diones.
Yamaguchi T; Miura K; Usui T; Unno R; Matsumoto Y; Fukushima M; Mizuno K; Kondo Y; Baba Y; Kurono M
Arzneimittelforschung; 1994 Mar; 44(3):344-8. PubMed ID: 8192700
[TBL] [Abstract][Full Text] [Related]
3. Biological activities and quantitative structure-activity relationships of spiro[imidazolidine-4,4'(1'H)-quinazoline]-2,2',5(3'H)-triones as aldose reductase inhibitors.
Yamagishi M; Yamada Y; Ozaki K; Asao M; Shimizu R; Suzuki M; Matsumoto M; Matsuoka Y; Matsumoto K
J Med Chem; 1992 May; 35(11):2085-94. PubMed ID: 1597858
[TBL] [Abstract][Full Text] [Related]
4. Spiro hydantoin aldose reductase inhibitors.
Sarges R; Schnur RC; Belletire JL; Peterson MJ
J Med Chem; 1988 Jan; 31(1):230-43. PubMed ID: 3121857
[TBL] [Abstract][Full Text] [Related]
5. CP-45,634: a novel aldose reductase inhibitor that inhibits polyol pathway activity in diabetic and galactosemic rats.
Peterson MJ; Sarges R; Aldinger CE; MacDonald DP
Metabolism; 1979 Apr; 28(4 Suppl 1):456-61. PubMed ID: 122297
[TBL] [Abstract][Full Text] [Related]
6. Novel spirosuccinimide aldose reductase inhibitors derived from isoquinoline-1,3-diones: 2-[(4-bromo-2-fluorophenyl)methyl]-6- fluorospiro[isoquinoline-4(1H),3'-pyrrolidine]-1,2',3,5'(2H)-tetrone and congeners. 1.
Malamas MS; Hohman TC; Millen J
J Med Chem; 1994 Jun; 37(13):2043-58. PubMed ID: 8027986
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and evaluation of novel aldose reductase inhibitors: Effects on lens protein kinase Cgamma.
Lewis S; Karrer J; Saleh S; Chan X; Tan Z; Hua D; McGill J; Pang YP; Fenwick B; Brightman A; Takemoto D
Mol Vis; 2001 Jul; 7():164-71. PubMed ID: 11483892
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and rat lens aldose reductase inhibitory activity of some benzopyran-2-ones.
Brubaker AN; DeRuiter J; Whitmer WL
J Med Chem; 1986 Jun; 29(6):1094-9. PubMed ID: 3086557
[TBL] [Abstract][Full Text] [Related]
9. Spiro hydantoin aldose reductase inhibitors derived from 8-aza-4-chromanones.
Sarges R; Goldstein SW; Welch WM; Swindell AC; Siegel TW; Beyer TA
J Med Chem; 1990 Jul; 33(7):1859-65. PubMed ID: 2113948
[TBL] [Abstract][Full Text] [Related]
10. Spirohydantoin derivatives of thiopyrano[2,3-b]pyridin-4(4H)-one as potent in vitro and in vivo aldose reductase inhibitors.
Da Settimo F; Primofiore G; La Motta C; Salerno S; Novellino E; Greco G; Lavecchia A; Laneri S; Boldrini E
Bioorg Med Chem; 2005 Jan; 13(2):491-9. PubMed ID: 15598571
[TBL] [Abstract][Full Text] [Related]
11. Synthesis of new arylsulfonylspiroimidazolidine-2',4'-diones and study of their effect on stimulation of insulin release from MIN6 cell line, inhibition of human aldose reductase, sorbitol accumulations in various tissues and oxidative stress.
Iqbal Z; Morahan G; Arooj M; Sobolev AN; Hameed S
Eur J Med Chem; 2019 Apr; 168():154-175. PubMed ID: 30818176
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and biological activity of spirocyclic benzopyran imidazolone potassium channel openers.
Gadwood RC; Kamdar BV; Dubray LA; Wolfe ML; Smith MP; Watt W; Mizsak SA; Groppi VE
J Med Chem; 1993 May; 36(10):1480-7. PubMed ID: 8496916
[TBL] [Abstract][Full Text] [Related]
13. 1-Benzopyran-4-one antioxidants as aldose reductase inhibitors.
Costantino L; Rastelli G; Gamberini MC; Vinson JA; Bose P; Iannone A; Staffieri M; Antolini L; Del Corso A; Mura U; Albasini A
J Med Chem; 1999 Jun; 42(11):1881-93. PubMed ID: 10354396
[TBL] [Abstract][Full Text] [Related]
14. Novel and potent aldose reductase inhibitors: 4-benzyl- and 4-(benzothiazol-2-ylmethyl)-3,4-dihydro-3-oxo-2H-1,4-benzothiazine-2-ac etic acid derivatives.
Aotsuka T; Hosono H; Kurihara T; Nakamura Y; Matsui T; Kobayashi F
Chem Pharm Bull (Tokyo); 1994 Jun; 42(6):1264-71. PubMed ID: 8069975
[TBL] [Abstract][Full Text] [Related]
15. Spiro oxazolidinedione aldose reductase inhibitors.
Schnur RC; Sarges R; Peterson MJ
J Med Chem; 1982 Dec; 25(12):1451-4. PubMed ID: 6818344
[TBL] [Abstract][Full Text] [Related]
16. Novel, highly potent aldose reductase inhibitors: (R)-(-)-2-(4-bromo-2-fluorobenzyl)-1,2,3,4- tetrahydropyrrolo[1,2-a]pyrazine -4-spiro-3'-pyrrolidine-1,2',3,5'-tetrone (AS-3201) and its congeners.
Negoro T; Murata M; Ueda S; Fujitani B; Ono Y; Kuromiya A; Komiya M; Suzuki K; Matsumoto J
J Med Chem; 1998 Oct; 41(21):4118-29. PubMed ID: 9767647
[TBL] [Abstract][Full Text] [Related]
17. Normalization of lens protein kinase Cgamma in galactosemic dogs by a novel aldose reductase inhibitor.
Takemoto DJ; Harris R; Brightman A; McGill J; Hua D; Davidson H; Fenwick B; Wagner LM
Vet Ophthalmol; 2004; 7(3):163-7. PubMed ID: 15091323
[TBL] [Abstract][Full Text] [Related]
18. N-substituted spirosuccinimide, spiropyridazine, spiroazetidine, and acetic acid aldose reductase inhibitors derived from isoquinoline-1,3-diones. 2.
Malamas MS; Hohman TC
J Med Chem; 1994 Jun; 37(13):2059-70. PubMed ID: 8027987
[TBL] [Abstract][Full Text] [Related]
19. Structure-activity studies of aldose reductase inhibitors containing the 4-oxo-4h-chromen ring system.
Kador PF; Sharpless NE
Biophys Chem; 1978 Mar; 8(1):81-5. PubMed ID: 417745
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and biological evaluation of 2'-oxo-2,3-dihydro-3'H- spiro[chromene-4,5'-[1,3]oxazolidin]-3'yl]acetic acid derivatives as aldose reductase inhibitors.
Rapposelli S; Da Settimo F; Digiacomo M; La Motta C; Lapucci A; Sartini S; Vanni M
Arch Pharm (Weinheim); 2011 Jun; 344(6):372-85. PubMed ID: 21319207
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]